KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alnylam Pharmaceuticals (ALNY) Cash & Current Investments (2016 - 2025)

Alnylam Pharmaceuticals' Cash & Current Investments history spans 17 years, with the latest figure at $1.7 billion for Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 38.31% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $1.7 billion, down 38.31%, while the annual FY2025 figure was $1.7 billion, 38.31% down from the prior year.
  • Cash & Current Investments reached $1.7 billion in Q4 2025 per ALNY's latest filing, down from $2.7 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $2.7 billion in Q3 2025 to a low of $436.5 million in Q1 2021.
  • Average Cash & Current Investments over 5 years is $1.6 billion, with a median of $1.8 billion recorded in 2021.
  • The largest YoY upside for Cash & Current Investments was 336.06% in 2021 against a maximum downside of 66.53% in 2021.
  • A 5-year view of Cash & Current Investments shows it stood at $2.4 billion in 2021, then plummeted by 62.18% to $896.7 million in 2022, then soared by 170.8% to $2.4 billion in 2023, then rose by 10.63% to $2.7 billion in 2024, then crashed by 38.31% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ALNY's Cash & Current Investments are $1.7 billion (Q4 2025), $2.7 billion (Q3 2025), and $1.1 billion (Q2 2025).